Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • About
    • Our Story
    • CIFAR 40
    • Awards
    • Partnerships
    • President’s Message
    • Publications & Reports
    • Careers
    • Equity, Diversity & Inclusion
  • News
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Staff Directory
    • Leadership
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
    • Global Call for Ideas
    • Action on Covid-19
  • Events
    • Public Events
    • Invitation-only Meetings
  • Support Us
  • fr
  • Home
  • Bio

Follow Us

post_content

David Denning

Appointment

  • Advisor
  • Fungal Kingdom: Threats & Opportunities

Connect

Website

About

David W. Denning is an infectious diseases clinician with expertise in fungal diseases.

He serves as the chief executive of the Global Action Fund for Fungal infections (GAFFI) and professor of Infectious Diseases and Global Health at the University of Manchester, UK. Denning manages the National Aspergillosis Centre, Manchester, a referral centre in the UK for all patients with chronic pulmonary aspergillosis. His current academic interests are chronic and allergic pulmonary fungal disease, the global burden of fungal infection, resistance in aspergillus, and the development of new antifungal agents.

Awards

  • Edouard Drouhet medal, European Confederation of Medical Mycology, 2017
  • Third P Talwar Oration, Chandigarh, India, 2015
  • Fellow, Academy of Medical Sciences, 2010
  • MacFarlane Burnett Lecturer, Australasian Society of Infectious Diseases, 2005

Relevant Publications

  • Page, I.D., Byanyima, R., Hosmane, S., Onyachi N.,… Denning, D.W. (2019 ). Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Eur Resp J, 18(53), pii: 1801184. DOI: 10.1183/13993003.01184-2018.

  • Denning, D.W., Kneale, M., Sobel, J.D., & Rautemaa-Richardson, R. (2018). Global burden of recurrent vulvovaginal candidiasis. Lancet Infect Dis, 18(11), e339-e347. DOI: 10.1016/S1473-3099(18)30103-8.

  • Denning, D.W., Perlin, D.S., Muldoon, E.G., Colombo, A.L., et al. (2017). Delivering on the antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg Infect Dis,23(2), 177-183. DOI: 10.3201/eid2302.152042

  • Cole, D.C., Govender, N.P., Chakrabarti, C., Sacarlal, J. (2017). Improving fungal disease identification and management – combined health systems and public health approaches are needed. Lancet Infect Dis, 17(12), e412-e419. DOI: 10.1016/S1473-3099(17)30308-0

  • Bongomin, F., Gago, S., Oladele, R.O., & Denning, D.W. (2017). Global and national prevalence of fungal diseases-estimate precision. J Fungi (Basel), 3(4), pii:E57. DOI: 10.3390/jof3040057.

Institution

  • University of Manchester

Department

Division of Infection, Immunity & Respiratory Medicine

Education

  • MBBS (Bachelor of Medicine and Bachelor of Surgery) University of London

Country

  • United Kingdom

Support Us

CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.

Donate Now
CIFAR header logo

Subscribe

Stay up to date on news & ideas from CIFAR.

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2022 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more